Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


UTokyo IPC sets up First Round
First Round's inaugural cohort includes a manga comic translation tool developer and a company working on synthetic options for creating salmon.
Neighborly leaves the municipal precinct
Stanford-backed micro public finance platform Neighborly has paused the payroll in a concerted attempt to restructure the business and avert insolvency.
Daily deal net: October 10, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Fazua stays unfazed to collect $16.5m
UVC Partners returned to back Fazua together with the electric bike drive system maker's other existing investors and an EIB-run venture debt provider.
Stanford fails in bid for restraining order
Stanford University general counsel Debra Zumwalt reportedly hoped to prevent further legal filings against her and other Stanford trustees.
WVU presides over Vantage Ventures
The Vantage Ventures incubator will aim to realise West Virginia University's goal of making West Virginia a startup powerhouse.
Biontech binds itself to public markets
Johannes Gutenberg University of Mainz's cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.
Aprea closes $97.8m IPO
The underwriters for Karolinska Institute spinout Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.

Other News

Kappeler captains FIT’s investment team
EPFL-backed Foundation for Technology Innovation has appointed David Kappeler as director and head of investments.
Apple screens iKinema for acquisition
Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.
Compton-Bishop hustles on from Warwick Ventures
Quentin Compton-Bishop has resigned as CEO of Warwick Ventures, but said he would continue to be involved in university venturing.
Aprea collects $85m in IPO proceeds
Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.
CSU generates six spinouts
CSU Ventures boosted its licensing income by more than two-fold and established six new spinouts during the 2018-19 academic year.
Huawei arrives at OSI
Huawei has been revealed as an LP in Oxford Sciences Innovation, having made its investment late last year before the university decided to block the corporate from philanthropic donations.

Editor's Picks

It’s not about the money
Lessons from the GUV Summit in Houston, Texas, this month
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
UCL Technology Fund: an unparalleled approach to commercialisation
Editor Thierry Heles sits down with David Grimm (pictured), manager of the UCL Technology Fund, to find out what makes the fund unique among its UK and international peers.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
test reg